Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Untreated B-CLL”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00858117
What this trial is testing

A Phase II Trial of Alemtuzumab and Rituximab in Patients With Previously Untreated CLL

Who this might be right for
Leukemia
Northwestern University 30
Testing effectiveness (Phase 2)Ended earlyNCT01044745
What this trial is testing

Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+108 more
University of Nebraska 20
Testing effectiveness (Phase 2)Study completedNCT02420912
What this trial is testing

Nivolumab and Ibrutinib in Treating Patients With Relapsed, Refractory, or High-Risk Untreated Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Richter Transformation

Who this might be right for
Loss of Chromosome 17pRecurrent Chronic Lymphocytic LeukemiaRecurrent Small Lymphocytic Lymphoma+3 more
M.D. Anderson Cancer Center 37
Not applicableActive Not RecruitingNCT02414022
What this trial is testing

Economic Analysis of Alliance A041202 CLL Study

Who this might be right for
Chronic Lymphocytic Leukemia
Canadian Cancer Trials Group 55
Testing effectiveness (Phase 2)Study completedNCT01520922
What this trial is testing

Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Leukaemia, Lymphocytic, Chronic
Novartis Pharmaceuticals 99
Not applicableStudy completedNCT00003538
What this trial is testing

Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Post-approval studies (Phase 4)UnknownNCT00131313
What this trial is testing

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Who this might be right for
Chronic Lymphocytic Leukemia
East Valley Hematology and Oncology Medical Group 180
Testing effectiveness (Phase 2)Study completedNCT01133743
What this trial is testing

Open-Label Study of Lenalidomide in Combination With Oral Dexamethasone in the Treatment of Previously Untreated, Symptomatic Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
University Health Network, Toronto 31
Not applicableStudy completedNCT00919425
What this trial is testing

S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
SWOG Cancer Research Network 1,294
Testing effectiveness (Phase 2)Looking for participantsNCT06544785
What this trial is testing

Zanubrutinib With Obinutuzumab in Untreated Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
PETHEMA Foundation 106
Not applicableStudy completedNCT02553447
What this trial is testing

Cholecalciferol in Newly Diagnosed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia With Vitamin D Deficiency

Who this might be right for
Chronic Lymphocytic LeukemiaNon-Hodgkin LymphomaUntreated Chronic Lymphocytic Leukemia+1 more
University of Nebraska 197
Testing effectiveness (Phase 2)Ended earlyNCT00751296
What this trial is testing

Study of Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukaemia
University Health Network, Toronto 27
Testing effectiveness (Phase 2)Study completedNCT00003829
What this trial is testing

Chemotherapy in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia
Alliance for Clinical Trials in Oncology 34
Testing effectiveness (Phase 2)Study completedNCT00230282
What this trial is testing

Phase 2 Fludarabine, Cytoxan and FCCAM <Alemtuzumab> in Untreated B-Cell Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaB-cell LeukemiaChronic Leukemia+1 more
Steven E. Coutre 25
Testing effectiveness (Phase 2)Study completedNCT01024010
What this trial is testing

Ofatumumab, Pentostatin, and Cyclophosphamide in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaStage 0 Chronic Lymphocytic LeukemiaStage I Chronic Lymphocytic Leukemia+7 more
Mayo Clinic 82
Testing effectiveness (Phase 2)Study completedNCT01868893
What this trial is testing

An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Genentech, Inc. 20
Testing effectiveness (Phase 2)Study completedNCT00410163
What this trial is testing

Ofatumumab With Fludarabine and Cyclophosphamide in B-CLL Patients

Who this might be right for
Leukaemia, Lymphocytic, Chronic
GlaxoSmithKline 61
Early research (Phase 1)UnknownNCT00004036
What this trial is testing

Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersDrug/Agent Toxicity by Tissue/OrganLeukemia+5 more
The Cleveland Clinic 30
Testing effectiveness (Phase 2)Study completedNCT00004857
What this trial is testing

Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia
Alliance for Clinical Trials in Oncology 86
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07624799
What this trial is testing

Fixed Duration Treatment With Combined Pirtobrutinib and Short Course Immuno-chemotherapy in Fit Patients With Previously Untreated Symptomatic Chronic Lymphocytic Leukemia (CLL).

Who this might be right for
CLL (Chronic Lymphocytic Leukemia)
French Innovative Leukemia Organisation 82
Next Page